Hot weather, exercise, vomiting, and diarrhea may cause dehydration even among those who drink enough water. When you’re not properly hydrated, your body cannot function at its peak. In the worst case scenario, you may experience fever and chills, dizziness, fainting, low blood pressure, and even death. No matter the cause, there are ways to مزید پڑھیں

AstraZeneca and Merck said on Wednesday their blockbuster cancer treatment Lynparza won approval in the European Union for treating patients with a form of pancreatic cancer. The approval was based on results from a late-stage trial in which Lynparza nearly doubled the lifespan of patients without disease progression or death when compared with placebo. Lynparza, مزید پڑھیں

More than a third of the world’s countries say they are at risk of running out of life-saving AIDS drugs because of disruptions to supply lines and other problems caused by the COVID-19 pandemic, the World Health Organization said on Monday. Twenty-four out of those 73 nations have already reported critically low supplies of the مزید پڑھیں

A large number of nurses staged a protest near the Sindh Chief Minister’s House at PIDC traffic intersection on Monday. They demanded that the government make payment of their outstanding salaries and regularise their services. The protesters attempted to march towards the CM House to present their demands to Chief Minister Murad Ali Shah but مزید پڑھیں

The northwestern Spanish region of Galicia imposed restrictions on about 70,000 people on Sunday following a COVID-19 outbreak, a day after Catalonia also introduced a local lockdown to curb the spread of the coronavirus. People living in A Marina along Spain’s northern coast in the province of Lugo will not be able to leave the مزید پڑھیں

The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality. The setback came as the WHO also reported more than 200,000 new cases globally of the disease for the first مزید پڑھیں

The European Commission said on Friday it had given conditional approval for the use of antiviral remdesivir in severe COVID-19 patients following an accelerated review process, making it the region’s first therapy to be authorised to treat the virus. The move comes just a week after the European Medicines Agency (EMA) gave its go-ahead for مزید پڑھیں

Some governments in Europe and Asia said on Wednesday they have enough of Gilead’s COVID-19 anti-viral remdesivir for now despite fears of shortages since the U.S. drugmaker pledged most output to its home market for the next three months. The pharmaceutical company’s move stirred the global debate about equitable access to drugs and brought concerns مزید پڑھیں

A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said on Wednesday. The drug is one of 17 being tested on humans in a frantic global race to find a vaccine the world is مزید پڑھیں

Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the next three months. The price tag is slightly below the range of $2,520 to $2,800 suggested last week by US مزید پڑھیں